Finance & economics | Buttonwood
Could the vaccine help ailing emerging-market shares?
The American election and the news on the jab have renewed investors’ appetite for risk
Editor’s note: Some of our covid-19 coverage is free for readers of The Economist Today, our daily newsletter. For more stories and our pandemic tracker, see our hub
This article appeared in the Finance & economics section of the print edition under the headline “Coming out of the ultracold”
Finance & economics November 14th 2020
- What a vaccine means for America’s economy
- News of an effective vaccine injects optimism into markets
- Could the vaccine help ailing emerging-market shares?
- Demand for American grain is surging
- Will Turkey’s new economic officials win over investors?
- Klarna, a Swedish payments unicorn, wants to conquer America
- Why relations between economists and epidemiologists have been testy
From the November 14th 2020 edition
Discover stories from this section and more in the list of contents
Explore the editionMore from Finance & economics
Do tariffs raise inflation?
Usually. But the bigger problem is that they harm economic growth and innovation
European governments struggle to stop rich people from fleeing
Exit taxes are popular, and counter-productive
Saba Capital wages war on underperforming British investment trusts
How many will end up in Boaz Weinstein’s sights?
Has Japan truly escaped low inflation?
Its central bankers are increasingly hopeful
How American bankers dodged the MAGA carnage
The masters of the universe have escaped an anti-globalist revolt
China’s financial system is under brutal pressure
When will something break?